With Companion Dx Guidance Nearing Release, FDA's Mansfield Offers Some 'Provisional' Advice
April 13, 2011
With Companion Dx Guidance Nearing Release, FDA's Mansfield Offers Some 'Provisional' Advice
Without speculating on a specific release date for the draft document, FDA's Elizabeth Mansfield said the companion diagnostics guidance is "definitely moving" through the agency.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Q&A: CDRH's Gutierrez, Mansfield Discuss Ongoing Regulatory Efforts in Personalized Medicine
January 2, 2013 / Pharmacogenomics Reporter - Ventana's Growing Companion Dx Focus Mirrors Parent Roche's Investment in Personalized Rx
January 18, 2012 / Pharmacogenomics Reporter - UK's NICE Backs Iressa Coverage at Fixed Price; NHS Pays for Genetic Testing
June 2, 2010 / Pharmacogenomics Reporter - FDA Approves Dako's HER2 IQFISH Assay
February 15, 2013 / GenomeWeb Daily News - Qiagen's Experience Developing KRAS CDx for Erbitux Yields Lessons for Rx/Dx Development
November 28, 2012 / Pharmacogenomics Reporter